|
|
|
Volumn 24, Issue , 1994, Pages S32-S37
|
|
The evolving role of angiotensin-converting enzyme inhibition in heart failure: Expanding the protective envelope
|
|
Author keywords
Angiotensin converting enzyme inhibitors; Congestive heart failure; Mortality trials; Myocardial infarction
|
|
Indexed keywords
CAPTOPRIL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
ENALAPRILAT;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
LISINOPRIL;
MAGNESIUM;
NITRATE;
PLACEBO;
PRAZOSIN;
ACUTE HEART INFARCTION;
ADULT;
AGED;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY RISK;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MIXTURE;
HUMAN;
HYPERTENSION;
HYPOTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VASODILATATION;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
LONGITUDINAL STUDIES;
MALE;
MYOCARDIAL INFARCTION;
RISK FACTORS;
UNITED STATES;
VASODILATOR AGENTS;
|
|
EID: 0028054265
PISSN: 01602446
EISSN: 15334023
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|
